Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Recent trends reveal a sharp rise in cancer cases in India, with younger patients and a lack of effective screening programs ...

Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.

Phillip Frost, CEO and Chairman of OPKO Health, Inc. (NASDAQ:OPK), recently acquired a significant number of shares in the ...

Merck MRK will report its fourth-quarter and full-year 2024 earnings on Feb. 4, before market open. The Zacks Consensus ...

A study of men with a family history of prostate cancer has discovered an inherited form of prostate cancer. The inherited ...

Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that could ...

The urine test, called MyProstateScore 2.0, or MPS2, looks at 18 different genes linked to high-grade prostate cancer. The researchers had previously demonstrated that the test was effective in ...

The inherited mutated gene WNT9B, which functions normally in embryonic prostate development, increases risk of adult prostate cancer, according to the Vanderbilt University Medical Center study ...

First patient treated in Phase II portion of clinical trial in metastatic prostate cancer at the West Los Angeles Veterans Administration ...

INmune Bio (INMB) has an ongoing Phase I/II trial in men with metastatic castration-resistant prostate cancer. The Company announced the ...

Pfizer Inc. will present the latest results from its leading genitourinary (GU) portfolio at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium taking place February ...